SPRB SPRUCE BIOSCIENCES, INC.
Nasdaq · SEC CIK 1683553 · EDGAR
- Bought, last 12 months
- $9,170 2 purchases by 1 insiders
- Sold, last 12 months
- $9,842 2 sales by 1 insiders
- Filings on record
- 91 since 2021-07-06, latest 2026-07-29 16:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Parkman Healthcare Partners LLC | 10% | $9,170 | $9,842 |
| Szwarcberg Javier B. | CEO, Dir | — | — |
| Ways Douglas Kirk | Interim Chief Medical Off, Dir | — | — |
| Gharib Samir M. | Pres AND CFO | — | — |
Transactions 54
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-09 16:15 | 2026-06-30 | SPRB | Szwarcberg Javier B. | CEO, Dir | A - Grant | $4.53 | +266 | 19.3K | +1% | +$1,205 | |
| D | 2026-01-21 | 2025-12-11 | SPRB | Ways Douglas Kirk | Interim Chief Medical Off, Dir | M - OptEx | $0.00 | +1,250 | 1,250 | New | $0 |
| 2026-01-05 | 2025-12-31 | SPRB | Szwarcberg Javier B. | CEO, Dir | A - Grant | $4.53 | +4,690 | 19.0K | +33% | +$21.2K | |
| DM | 2025-12-17 | 2025-12-15 | SPRB | Gharib Samir M. | Pres AND CFO | M - OptEx | $0.00 | +1,009 | 8,447 | +14% | $0 |
| DM | 2025-12-17 | 2025-12-15 | SPRB | Gharib Samir M. | Pres AND CFO | F - Tax | $80.67 | -362 | 8,263 | -4% | -$29.2K |
| DM | 2025-12-17 | 2025-12-15 | SPRB | Szwarcberg Javier B. | CEO, Dir | F - Tax | $80.67 | -1,360 | 14.3K | -9% | -$109.7K |
| DM | 2025-12-17 | 2025-12-15 | SPRB | Szwarcberg Javier B. | CEO, Dir | M - OptEx | $0.00 | +2,676 | 14.9K | +22% | $0 |
| DM | 2025-12-12 | 2025-12-10+ | SPRB | Szwarcberg Javier B. | CEO, Dir | F - Tax | $87.96 | -2,622 | 10.2K | -20% | -$230.6K |
| DM | 2025-12-12 | 2025-12-10+ | SPRB | Szwarcberg Javier B. | CEO, Dir | M - OptEx | $0.00 | +6,146 | 15.2K | +68% | $0 |
| DM | 2025-12-12 | 2025-12-10+ | SPRB | Gharib Samir M. | Pres AND CFO | M - OptEx | $0.00 | +2,414 | 8,296 | +41% | $0 |
| DM | 2025-12-12 | 2025-12-10+ | SPRB | Gharib Samir M. | Pres AND CFO | F - Tax | $87.83 | -864 | 7,616 | -10% | -$75.9K |
| D | 2025-10-22 | 2025-10-20 | SPRB | Szwarcberg Javier B. | CEO, Dir | M - OptEx | $0.00 | +4,784 | 11.0K | +77% | $0 |
| D | 2025-10-22 | 2025-10-20 | SPRB | Szwarcberg Javier B. | CEO, Dir | F - Tax | $148.16 | -1,539 | 9,474 | -14% | -$228.0K |
| D | 2025-10-22 | 2025-10-20 | SPRB | Gharib Samir M. | Pres AND CFO | M - OptEx | $0.00 | +2,053 | 6,727 | +44% | $0 |
| D | 2025-10-22 | 2025-10-20 | SPRB | Gharib Samir M. | Pres AND CFO | F - Tax | $148.16 | -661 | 6,066 | -10% | -$97.9K |
| MI | 2025-10-15 | 2025-10-06 | SPRB | Parkman Healthcare Partners LLC | 10% | S - Sale | $19.15 | -257 | 1,050 | -20% | -$4,921 |
| I | 2025-10-15 | 2025-10-06 | SPRB | Parkman Healthcare Partners LLC | 10% | P - Purchase | $17.91 | +256 | 1,307 | +24% | +$4,585 |
| MI | 2025-10-08 | 2025-10-06 | SPRB | Parkman Healthcare Partners LLC | 10% | S - Sale | $19.15 | -257 | 1,050 | -20% | -$4,921 |
| I | 2025-10-08 | 2025-10-06 | SPRB | Parkman Healthcare Partners LLC | 10% | P - Purchase | $17.91 | +256 | 1,307 | +24% | +$4,585 |
| DM | 2024-12-20 | 2024-12-10+ | SPRB | Szwarcberg Javier B. | CEO, Dir | M - OptEx | $0.00 | +559.5K | 427.8K | New | $0 |
| DM | 2024-12-20 | 2024-12-10+ | SPRB | Szwarcberg Javier B. | CEO, Dir | F - Tax | $0.4862 | -199.6K | 395.8K | -34% | -$97.1K |
| DM | 2024-12-20 | 2024-12-10+ | SPRB | Gharib Samir M. | Pres AND CFO | F - Tax | $0.4905 | -82.0K | 350.6K | -19% | -$40.2K |
| DM | 2024-12-20 | 2024-12-10+ | SPRB | Gharib Samir M. | Pres AND CFO | M - OptEx | $0.00 | +229.8K | 356.8K | +181% | $0 |
| DM | 2024-12-20 | 2024-12-10+ | SPRB | Charlton Ralph William III | Chief MEDICAL Off | F - Tax | $0.4869 | -58.8K | 140.9K | -29% | -$28.6K |
| DM | 2024-12-20 | 2024-12-10+ | SPRB | Charlton Ralph William III | Chief MEDICAL Off | M - OptEx | $0.00 | +164.8K | 150.4K | New | $0 |
| 2024-03-25 | 2024-03-21 | SPRB | Novo Holdings A/S | 10% | S - Sale | $0.75 | -465.0K | 2.55M | -15% | -$348.8K | |
| M | 2024-03-20 | 2024-03-18+ | SPRB | Novo Holdings A/S | 10% | S - Sale | $0.7587 | -1.79M | 3.38M | -35% | -$1.36M |
| 2024-03-18 | 2024-03-14 | SPRB | Novo Holdings A/S | 10% | S - Sale | $0.89 | -1.91M | 4.81M | -28% | -$1.70M | |
| 2024-01-03 | 2023-12-29 | SPRB | Charlton Ralph William III | Chief Medical Off | A - Grant | $0.98 | +9,361 | 55.4K | +20% | +$9,174 | |
| 2024-01-03 | 2023-12-29 | SPRB | Gharib Samir M. | Pres, CFO | A - Grant | $0.98 | +11.3K | 202.8K | +6% | +$11.0K | |
| DM | 2023-12-18 | 2023-12-15 | SPRB | Gharib Samir M. | Pres, CFO | F - Tax | $1.66 | -36.1K | 167.2K | -18% | -$59.9K |
| DM | 2023-12-18 | 2023-12-15 | SPRB | Gharib Samir M. | Pres, CFO | M - OptEx | $0.00 | +112.2K | 190.4K | +144% | $0 |
| D | 2023-12-18 | 2023-12-15 | SPRB | Charlton Ralph William III | Chief Medical Off | F - Tax | $1.66 | -11.0K | 46.0K | -19% | -$18.2K |
| D | 2023-12-18 | 2023-12-15 | SPRB | Charlton Ralph William III | Chief Medical Off | M - OptEx | $0.00 | +31.8K | 57.0K | +126% | $0 |
| D | 2023-12-18 | 2023-12-15 | SPRB | Szwarcberg Javier B. | CEO, Dir | F - Tax | $1.66 | -38.4K | 107.3K | -26% | -$63.7K |
| D | 2023-12-18 | 2023-12-15 | SPRB | Szwarcberg Javier B. | CEO, Dir | M - OptEx | $0.00 | +111.0K | 145.7K | +320% | $0 |
| 2023-07-05 | 2023-06-30 | SPRB | Szwarcberg Javier B. | CEO, Dir | A - Grant | $0.98 | +20.0K | 34.7K | +136% | +$19.6K | |
| 2023-07-05 | 2023-06-30 | SPRB | Charlton Ralph William III | Chief Medical Off | A - Grant | $0.98 | +12.4K | 25.2K | +96% | +$12.1K | |
| D | 2023-07-05 | 2023-06-30 | SPRB | Gharib Samir M. | Pres, CFO | F - Tax | $2.15 | -25.9K | 115.4K | -18% | -$55.8K |
| D | 2023-07-05 | 2023-06-30 | SPRB | Gharib Samir M. | Pres, CFO | M - OptEx | — | +75.0K | 141.3K | +113% | — |
| D | 2023-07-05 | 2023-06-30 | SPRB | Gharib Samir M. | Pres, CFO | A - Grant | $0.98 | +10.5K | 66.3K | +19% | +$10.3K |
| DI | 2023-05-16 | 2023-02-16 | SPRB | O'Donnell Niall | Dir | P - Purchase | $3.17 | +630.4K | 1.33M | +91% | +$2.00M |
| D | 2023-02-21 | 2023-02-16 | SPRB | Novo Holdings A/S | 10% | P - Purchase | $3.17 | +2.21M | 6.72M | +49% | +$7.00M |
| 2023-01-05 | 2022-12-30 | SPRB | Szwarcberg Javier B. | CEO, Dir | A - Grant | $0.93 | +14.7K | 14.7K | New | +$13.7K | |
| D | 2023-01-05 | 2022-12-30 | SPRB | Gharib Samir M. | Pres, CFO | A - Grant | $0.93 | +1 | 33.6K | +0.0% | +$0.93 |
| D | 2023-01-05 | 2023-01-03 | SPRB | Gharib Samir M. | Pres, CFO | M - OptEx | — | +37.5K | 71.1K | +112% | — |
| D | 2023-01-05 | 2023-01-03 | SPRB | Gharib Samir M. | Pres, CFO | F - Tax | $1.15 | -15.3K | 55.8K | -22% | -$17.6K |
| 2023-01-05 | 2022-12-30 | SPRB | Charlton Ralph William III | Chief Medical Off | A - Grant | $0.93 | +12.9K | 12.9K | New | +$12.0K | |
| D | 2022-07-05 | 2022-06-30 | SPRB | Gharib Samir M. | Pres, CFO | F - Tax | $1.74 | -13.0K | 33.6K | -28% | -$22.6K |
| D | 2022-07-05 | 2022-06-30 | SPRB | Gharib Samir M. | Pres, CFO | A - Grant | $1.48 | +5,446 | 46.6K | +13% | +$8,060 |
| D | 2022-07-05 | 2022-06-30 | SPRB | Gharib Samir M. | Pres, CFO | M - OptEx | — | +37.5K | 41.1K | +1,032% | — |
| D | 2022-01-05 | 2021-12-31 | SPRB | Gharib Samir M. | Pres, CFO | J - Other | $3.79 | +2,220 | 4,632 | +92% | +$8,414 |
| 2021-07-06 | 2021-06-30 | SPRB | KING RICHARD | CEO, Dir | J - Other | $9.53 | +2,230 | 2,230 | New | +$21.3K | |
| 2021-07-06 | 2021-06-30 | SPRB | Gharib Samir M. | CFO | J - Other | $9.53 | +1,412 | 1,412 | New | +$13.5K |
Purchase Sale Sale after option exercise All abbreviations